Home/ Crypto News/ BioNTech (BNTX) Stock Jumps 22% Following Moderna’s Cancer Vaccine Breakthrough

blockonomi Aug 20, 2026

BioNTech (BNTX) Stock Jumps 22% Following Moderna’s Cancer Vaccine Breakthrough

Stocks

BioNTech (BNTX) stock rallied 22% after Moderna's cancer vaccine trial success, but analysts say the gains may be short-lived. Here's why.

The post BioNTech (BNTX) Stock Jumps 22% Following Moderna’s Cancer Vaccine Breakthrough appeared first on Blockonomi.

Source: Source: Blockonomi